Clinical Trials Logo

Filter by:
NCT ID: NCT05615896 Terminated - Retinal Disease Clinical Trials

Data Collection With the P200TE and P200TxE

Start date: April 22, 2021
Phase: N/A
Study type: Interventional

The primary objective is to collect OCT scans on a modified P200TxE and P200TE.

NCT ID: NCT05614648 Terminated - Clinical trials for Lumbosacral Radiculopathy

Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet

SERENITY CM
Start date: June 19, 2023
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the treatment of low back and leg pain from sciatica.

NCT ID: NCT05609604 Terminated - Weight Loss Clinical Trials

Role of Transcranial Direct Current Stimulation in Appetite and Weight Control

TDCS
Start date: January 2017
Phase: N/A
Study type: Interventional

To study the effects of transcranial direct current stimulation (tDCS) on weight and appetite.

NCT ID: NCT05607342 Terminated - Clinical trials for Prostate Adenocarcinoma

Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the Prostate

PORT-MAP
Start date: January 3, 2023
Phase: Early Phase 1
Study type: Interventional

To evaluate the effect of Osanetant on testosterone levels in men with prostate cancer within 28 days of therapy.

NCT ID: NCT05604521 Terminated - Malaria Clinical Trials

A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI

Start date: December 6, 2022
Phase: Phase 1
Study type: Interventional

USSPZV7 is a randomized, phase 1, double-blind, placebo-controlled trial of Sanaria® PfSPZ Vaccine administered on Days 1, 8 and 29 by direct venous inoculation (DVI) to assess safety, tolerability, immunogenicity, and vaccine efficacy (VE) against heterologous controlled human malaria infection (CHMI) with the 7G8 clone of Plasmodium falciparum (Pf) conducted at 3 or 12 weeks after the third immunization. The trial is designed to determine if individuals living in a non-malaria endemic area such as the United States (US) are protected against heterologous CHMI conducted at these time points.

NCT ID: NCT05603624 Terminated - Chorioamnionitis Clinical Trials

Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term

Start date: September 2, 2021
Phase: N/A
Study type: Interventional

This prospective randomized controlled study examines whether the type of glove used (sterile vs clean) for cervical examination to assess progression in labor impacts the rates of intrapartum and/or postpartum infection in patients during labor or induction of labor at term.

NCT ID: NCT05602727 Terminated - Alzheimer's Disease Clinical Trials

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Start date: December 2, 2022
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to assess is to evaluate the safety and efficacy of MK-1942 as adjunctive therapy in participants with mild to moderate Alzheimer's Disease (AD) dementia.

NCT ID: NCT05597722 Terminated - Clinical trials for Cognitive Impairment

Addressing Cognitive Fog in Long-COVID-19 Patients

Start date: April 4, 2023
Phase: Phase 4
Study type: Interventional

This study will assess two options to help patients better manage the cognitive fog and emotional distress that may be associated with having Long-COVID. Long-COVID is post-COVID conditions or symptoms lasting more than four weeks after infection. Clinicians from the UPMC Long-COVID Clinic leading this study are evaluating the utility of computer-based evaluation of COVID-related cognitive fog and the helpfulness of two intervention strategies to treat moderate cognitive impairment using a randomized trial. The two intervention strategies include 1) a standardized dosing of amphetamine/dextroamphetamine medication that has been used to improve cognitive fog; and 2) a digital behavioral tool with an embedded health coach that is used on a mobile phone.

NCT ID: NCT05594940 Terminated - Clinical trials for Congestive Heart Failure

Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study

Start date: September 21, 2022
Phase:
Study type: Observational

The primary objective of this study is to evaluate the feasibility of a novel app to facilitate heart failure patients to acquire lung ultrasound images and evaluate the quality of those images to expert scans, and to evaluate for relationships between the ultrasound data and pulmonary pressure data from the Abbott CardioMEMS system.

NCT ID: NCT05591274 Terminated - Pain, Postoperative Clinical Trials

Virtual Reality Technology for Vasectomy Pain Modulation

Start date: November 17, 2022
Phase: N/A
Study type: Interventional

This study will evaluate whether or not wearing a virtual reality (VR) headset reduces pain and anxiety in patients undergoing vasectomy. The headset being used is the SmileyScope virtual reality interface, a device already undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. In this study, the SmileyScope virtual reality interface is considered an investigational device because it is not yet approved for use in adult males undergoing vasectomy.